Answers are grounded in this paper and cite their sources.
Multi-center validation demonstrates reliable labeling in biotinylated red blood cells, indicating potential for consistent results across different locations.
The standardized BioRBC protocol produces reliable, reproducible labeling with minimal inter-site variability. In vivo performance will be assessed in upcoming PTR24 studies comparing BioRBCs with dual radiolabeling using ⁵¹Cr and technetium-99m (99mTc).
No takes yet. Share an insight, caveat, or question.
Marschner et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: